Literature DB >> 11984

[Lactic acidosis in diabetics on biguanides (author's transl)].

P Wittmann, M Haslbeck, W Bachmann, H Mehnert.   

Abstract

A systematic search for cases of lactic acidosis among diabetics on biguanides revealed ten during an eight-month period, while in the preceding ten years not a single case had been definitely diagnosed. This represents a prevelance of 1 in 2000 patients admitted to hospital. All ten were over 60 years old and had previously been treated for heart failure. Most of them had suffered from renal insufficiency for some time. There was no case of biguanide overdosage. Criteria for the diagnosis of lactic acidosis are lactic concentration in blood averaging 18.4 mmol/l and a low pH, averaging 6.9. Serum-biguanide concentration (measured by radioimmuno-assay) was markedly increased. Most of the patients were in circulatory shock on admission or soon after and all of them had a history of gastro-intestinal complaints. Despite intensive treatment with insulin and glucose and careful correction of the acidosis with bicarbonate four of the ten patients died.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 11984     DOI: 10.1055/s-0028-1104832

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  7 in total

1.  Buformin suppresses proliferation and invasion via AMPK/S6 pathway in cervical cancer and synergizes with paclitaxel.

Authors:  Jing Li; Ling Chen; Qiuli Liu; Mei Tang; Yuan Wang; Jinjin Yu
Journal:  Cancer Biol Ther       Date:  2018-02-27       Impact factor: 4.742

2.  Buformin increases radiosensitivity in cervical cancer cells via cell-cycle arrest and delayed DNA-damage repair.

Authors:  Ling Chen; Ting Zhang; Qiuli Liu; Mei Tang; Yu'e Yang; Yuan Wang; Haifeng Qiu; Jinjin Yu
Journal:  Exp Biol Med (Maywood)       Date:  2018-10

Review 3.  Lactic acidosis in biguanide-treated diabetics: a review of 330 cases.

Authors:  D Luft; R M Schmülling; M Eggstein
Journal:  Diabetologia       Date:  1978-02       Impact factor: 10.122

4.  Effect of phenformin on hepatic balances of gluconeogenic substrates in man.

Authors:  G Dietze; M Wicklmayr; H Mehnert; H Czempiel; H G Henftling
Journal:  Diabetologia       Date:  1978-04       Impact factor: 10.122

5.  [Lactic acidosis--a possible complication in buformin-treated diabetics (author's transl)].

Authors:  D Deppermann; A Heidland; E Ritz; W Hörl
Journal:  Klin Wochenschr       Date:  1978-09-01

6.  Influence of phenformin and metformin on exercise induced lactataemia in patients with diabetes mellitus.

Authors:  P Björntorp; S Carlström; S E Fagerberg; L S Hermann; A G Holm; B Scherstén; J Ostman
Journal:  Diabetologia       Date:  1978-08       Impact factor: 10.122

7.  Inhibition of Chikungunya Virus Replication by 1-[(2-Methylbenzimidazol-1-yl) Methyl]-2-Oxo-Indolin-3-ylidene] Amino] Thiourea(MBZM-N-IBT).

Authors:  Priyadarsee Mishra; Abhishek Kumar; Prabhudutta Mamidi; Sameer Kumar; Itishree Basantray; Tanuja Saswat; Indrani Das; Tapas Kumar Nayak; Subhasis Chattopadhyay; Bharat Bhusan Subudhi; Soma Chattopadhyay
Journal:  Sci Rep       Date:  2016-02-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.